Mapping of the antibiotic market in Denmark, Finland, Norway and Sweden


PLATINEA (AP1 and AP4) and The Public Health Agency of Sweden have mapped the antibiotic market with focus on clinically prioritized antibiotics at risk for insufficient availability. Access to children's formulations is a particular problem. The results reveal noticeable differences between the Nordic countries despite likely similar medical needs, and indicate potential for harmonisation.

Go to the report on our publication page.

Last modified: 2023-03-03